1. Friedrich, MJ. Depression is the leading cause of disability around the world. JAMA 2017; 317: 1517.
Google Scholar | Crossref2. Ferrari, AJ, Charlson, FJ, Norman, RE, et al Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 2013; 10: e1001547.
Google Scholar | Crossref | Medline | ISI3. Milev, RV, Giacobbe, P, Kennedy, SH, et al Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder. Can J Psychiatry 2016; 61: 561–575.
Google Scholar4. Olin, B, Jayewardene, AK, Bunker, M, et al Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention. PLoS One 2012; 7: e48002.
Google Scholar | Crossref | Medline | ISI5. Maughan, D, Molodynski, A. An international perspective on the acceptability and sustainability of electroconvulsive therapy. BJPsych Int 2016; 13: 10–12.
Google Scholar | Crossref | Medline6. Lefaucheur, J-P, Aleman, A, Baeken, C, et al Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014–2018). Clin Neurophysiol 2020; 131: 474–528.
Google Scholar | Crossref | Medline7. Rossi, S, Antal, A, Bestmann, S, et al Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: expert Guidelines. Clin Neurophysiol 2020; 132: 269–306.
Google Scholar | Crossref | Medline8. Perera, T, George, MS, Grammer, G, et al The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul 2016; 99: 336–346.
Google Scholar | Crossref9. Wassermann, EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996. Electroencephalogr Clin Neurophysiol 1998; 108: 1–16.
Google Scholar | Crossref | Medline10. Endler, NS. The origins of electroconvulsive therapy (ECT). Convulsive Ther 1988; 4: 5–23.
Google Scholar | Medline11. Sarmiento, CI, San-Juan, D, Prasath, VBS. Letter to the Editor: brief history of transcranial direct current stimulation (tDCS): from electric fishes to microcontrollers. Psychol Med 2016; 46: 3259–3261.
Google Scholar | Crossref | Medline12. Troster, AI. Neuropsychology of deep brain stimulation in neurology and psychiatry. Front Biosci 2009; 14: 1857.
Google Scholar13. George, MS, Rush, AJ, Sackeim, HA, et al Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders. Int J Neuropsychopharmacol 2003; 6: 73–83.
Google Scholar | Crossref | Medline14. Bickford, RG, Guidi, M, Fortesque, P, et al Magnetic stimulation of human peripheral nerve and brain: response enhancement by combined magnetoelectrical technique. Neurosurgery 1987; 20: 110–116.
Google Scholar | Crossref | Medline | ISI15. Pascual-Leone, A, Catala, MD, Pascual-Leone Pascual, A. Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood. Neurology 1996; 46: 499–502.
Google Scholar | Crossref | Medline | ISI16. George, MS, Ketter, TA, Post, RM. Prefrontal cortex dysfunction in clinical depression. Depression 1994; 2: 59–72.
Google Scholar | Crossref17. George, MS, Wassermann, EM, Williams, WA, et al Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995; 6: 1853–1856.
Google Scholar | Crossref | Medline | ISI18. Kolbinger, HM, Höflich, G, Hufnagel, A, et al Transcranial magnetic stimulation (TMS) in the treatment of major depression—a pilot study. Hum Psychopharmacol Clin Exp 1995; 10: 305–310.
Google Scholar | Crossref | ISI19. O’Reardon, JP, Solvason, HB, Janicak, PG, et al Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62: 1208–1216.
Google Scholar20. George, MS, Lisanby, SH, Avery, D, et al Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 2010; 67: 507–516.
Google Scholar21. Fitzgerald, PB, Fountain, S, Daskalakis, ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol 2006; 117: 2584–2596.
Google Scholar | Crossref | Medline | ISI22. Soundara Rajan, T, Ghilardi, MFM, Wang, HY, et al Mechanism of action for rTMS: a working hypothesis based on animal studies. Front Physiol 2017; 8: 457.
Google Scholar | Crossref | Medline23. Diamond, D, Dunwiddie, T, Rose, G. Characteristics of hippocampal primed burst potentiation in vitro and in the awake rat. J Neurosci 1988; 8: 4079–4088.
Google Scholar | Crossref | Medline24. Huang, Y-Z, Edwards, MJ, Rounis, E, et al Theta burst stimulation of the human motor cortex. Neuron 2005; 45: 201–206.
Google Scholar | Crossref | Medline | ISI25. McCalley, DM, Lench, DH, Doolittle, JD, et al Determining the optimal pulse number for theta burst induced change in cortical excitability. Sci Rep 2021; 11: 8726.
Google Scholar | Crossref | Medline26. Filipčić, I, Filipčić, IŠ, Milovac Sučić, ŽS, et al Efficacy of repetitive transcranial magnetic stimulation using a figure-8-coil or an H1-Coil in treatment of major depressive disorder; A randomized clinical trial. J Psychiatr Res 2019; 114: 113–119.
Google Scholar | Crossref | Medline27. Nahas, Z, Lomarev, M, Roberts, DR, et al Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. Biol Psychiatry 2001; 50: 712–720.
Google Scholar | Crossref | Medline28. Stokes, MG, Chambers, CD, Gould, IC, et al Distance-adjusted motor threshold for transcranial magnetic stimulation. Clin Neurophysiol 2007; 118: 1617–1625.
Google Scholar | Crossref | Medline29. Stokes, MG, Chambers, CD, Gould, IC, et al Simple metric for scaling motor threshold based on scalp-cortex distance: application to studies using transcranial magnetic stimulation. J Neurophysiol 2005; 94: 4520–4527.
Google Scholar | Crossref | Medline | ISI30. Chung, SW, Rogasch, NC, Hoy, KE, et al The effect of single and repeated prefrontal intermittent theta burst stimulation on cortical reactivity and working memory. Brain Stimul 2018; 11: 566–574.
Google Scholar | Crossref | Medline31. Alkhasli, I, Sakreida, K, Mottaghy, FM, et al Modulation of fronto-striatal functional connectivity using transcranial magnetic stimulation. Front Hum Neurosci 2019; 13: 190.
Google Scholar | Crossref | Medline32. Levkovitz, Y, Isserles, M, Padberg, F, et al Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry 2015; 14: 64–73.
Google Scholar | Crossref | Medline | ISI33. Blumberger, DM, Vila-Rodriguez, F, Thorpe, KE, et al Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 2018; 391: 1683–1692.
Google Scholar | Crossref | Medline34. Pascual-Leone, A, Rubio, B, Pallardó, F, et al Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996; 348: 233–237.
Google Scholar | Crossref | Medline | ISI35. Beam, W, Borckardt, JJ, Reeves, ST, et al An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimul 2009; 2: 50–54.
Google Scholar36. Modak, A, Fitzgerald, PB. Personalising transcranial magnetic stimulation for depression using neuroimaging: a systematic review. World J Biological Psychiatry. Epub ahead of print 21 April 2021. DOI: 10.1080/15622975.2021.1907710.
Google Scholar | Crossref | Medline37. Weigand, A, Horn, A, Caballero, R, et al Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites. Biol Psychiatry 2018; 84: 28–37.
Google Scholar | Crossref | Medline38. Brunoni, AR, Chaimani, A, Moffa, AH, et al Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis. JAMA Psychiat 2016; 74: 143.
Google Scholar | Crossref39. Kar, SK. Predictors of response to repetitive transcranial magnetic stimulation in depression: a review of recent updates. Clin Psychopharm Neu 2019; 17: 25–33.
Google Scholar | Crossref | Medline40. Drysdale, AT, Grosenick, L, Downar, J, et al Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 2017; 23: 28–38.
Google Scholar | Crossref | Medline41. Cohen, RB, Boggio, PS, Fregni, F. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depress Anxiety 2009; 26: 682–688.
Google Scholar | Crossref | Medline | ISI42. Dunner, DL, Aaronson, ST, Sackeim, HA, et al A Multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry 2014; 75: 1394–1401.
Google Scholar | Crossref | Medline | ISI43. Senova, S, Cotovio, G, Pascual-Leone, A, et al Durability of antidepressant response to repetitive transcranial magnetic stimulation: systematic review and meta-analysis. Brain Stimul 2019; 12: 119–128.
Google Scholar | Crossref | Medline44. Fitzgerald, PB. Is Maintenance repetitive transcranial magnetic stimulation for patients with depression a valid therapeutic strategy. Clin Pharmacol Ther 2019; 106: 723–725.
Google Scholar | Crossref | Medline45. Rachid, F. Maintenance repetitive transcranial magnetic stimulation (rTMS) for relapse prevention in with depression: a review. Psychiatry Res 2018; 262: 363–372.
Google Scholar | Crossref | Medline46. Philip, NS, Dunner, DL, Dowd, SM, et al Can medication free, treatment-resistant, depressed patients who initially respond to tms be maintained off medications? A prospective, 12-month multisite randomized pilot study. Brain Stimul 2016; 9: 251–257.
Google Scholar | Crossref | Medline47. Wang, H-N, Wang, X-X, Zhang, R-G, et al Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: a randomized controlled trial. Transl Psychiatry 2017; 7: 1292, http://www.nature.com/articles/s41398-017-0001-x
Google Scholar48. Chang, J, Chu, Y, Ren, Y, et al Maintenance treatment of transcranial magnetic stimulation (TMS) for treatment-resistant depression patients responding to acute TMS treatment. Int J Physiol Pathophysiol Pharmacol 2020; 12: 128–133.
Google Scholar | Medline49. Lerner, AJ, Wassermann, EM, Tamir, DI. Seizures from transcranial magnetic stimulation 2012–2016: results of a survey of active laboratories and clinics. Clin Neurophysiol 2019; 130: 1409–1416.
Google Scholar | Crossref | Medline50. Martin, DM, McClintock, SM, Forst